These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12642173)

  • 41. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.
    Matusch A; Hurlemann R; Rota Kops E; Winz OH; Elmenhorst D; Herzog H; Zilles K; Bauer A
    J Neural Transm (Vienna); 2007; 114(11):1433-42. PubMed ID: 17541696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung as reservoir for antidepressants in pharmacokinetic drug interactions.
    Suhara T; Sudo Y; Yoshida K; Okubo Y; Fukuda H; Obata T; Yoshikawa K; Suzuki K; Sasaki Y
    Lancet; 1998 Jan; 351(9099):332-5. PubMed ID: 9652614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study.
    Moresco RM; Colombo C; Fazio F; Bonfanti A; Lucignani G; Messa C; Gobbo C; Galli L; Del Sole A; Lucca A; Smeraldi E
    Neuroimage; 2000 Oct; 12(4):452-65. PubMed ID: 10988039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of brain 5HT2 receptor binding potential with a single-dose PET paradigm.
    Petit Taboué MC; Baron JC
    Eur J Nucl Med; 1995 Jun; 22(6):585-6. PubMed ID: 7556308
    [No Abstract]   [Full Text] [Related]  

  • 49. Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine.
    Kundermann B; Hemmeter-Spernal J; Strate P; Gebhardt S; Huber MT; Krieg JC; Lautenbacher S
    J Psychiatr Res; 2009 Dec; 43(16):1253-61. PubMed ID: 19467668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measurement of changes in endogenous serotonin level by positron emission tomography with [
    Ikoma Y; Takuwa H; Nishino A; Maeda J; Kawamura K; Obata T; Zhang MR; Higuchi M; Suhara T
    Ann Nucl Med; 2021 Aug; 35(8):955-965. PubMed ID: 34101154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic analysis of [
    Pauwelyn G; Vlerick L; Dockx R; Verhoeven J; Dobbeleir A; Bosmans T; Peremans K; Vanhove C; Polis I; De Vos F
    BMC Vet Res; 2019 Nov; 15(1):415. PubMed ID: 31752848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET imaging of serotoninergic neurotransmission with [(11)C]DASB and [(18)F]altanserin after focal cerebral ischemia in rats.
    Martín A; Szczupak B; Gómez-Vallejo V; Plaza S; Padró D; Cano A; Llop J
    J Cereb Blood Flow Metab; 2013 Dec; 33(12):1967-75. PubMed ID: 23982048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Montgomery SA; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
    Braconnier A; Le Coent R; Cohen D;
    J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):22-9. PubMed ID: 12500073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
    Strobel M; Warnke A; Roth M; Schulze U
    Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
    Soares JC; van Dyck CH; Tan P; Zoghbi SS; Garg P; Soufer R; Baldwin RM; Fujita M; Staley JK; Fu X; Amici L; Seibyl J; Innis RB
    Psychiatry Res; 2001 Apr; 106(2):81-93. PubMed ID: 11306248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.